COMPASS Pathways plc
CMPSHealthcareNASDAQMedical Care Facilities
Scan Results
Daily timeframeCOMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. At a $1.84B market cap, COMPASS Pathways plc ranks as a small-cap company within healthcare. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa.
Market Cap
$1.84B
Beta
2.53
P/E (TTM)
—
P/E (Fwd)
-9.27
EPS (TTM)
$-3.81
EPS (Fwd)
$-1.43
ROE
-319.1%
ROA
-29.1%
Cash
$433.3M
Total Debt
$54.6M
Free CF
$249.9M
52W Change
159.4%
Annual Financials
Cash vs Debt
Where CMPS stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, CMPS finished 32.70% above its 150-day moving average ($9.97) and 45.70% above its 200-day moving average ($9.08). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is CMPS overbought or oversold?
At the September 3, 2026 close, CMPS's RSI(14) was 49.4, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
COMPASS Pathways plc holds $433.3M in cash against $54.6M in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. Annual free cash flow of $249.9M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of -319.1% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity.
With a beta above 1.5, CMPS tends to amplify broader market moves — both up and down. This higher volatility means larger price swings are common. With cash comfortably exceeding debt, CMPS has financial flexibility that may help navigate uncertain periods. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing CMPS.